Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Alliance Global Partners Downgrades T2 Biosystems to Neutral

Alliance Global Partners Downgrades T2 Biosystems to Neutral

Alliance Global Partners analyst Ben Haynor downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Neutral.

byBenzinga Newsdesk

July 7, 2022

1 minute read

Alliance Global Partners analyst Ben Haynor downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Neutral.

Baird Downgrades Boot Barn Holdings to Neutral, Announces $86 Price Target

By Benzinga Newsdesk

January 30, 8:11 AM

Baird analyst Jonathan Komp downgrades Boot Barn Holdings (NYSE:BOOT) from Outperform to Neutral and announces $86 price target.

BOOT

Citigroup Maintains Buy on Genpact, Lowers Price Target to $52

By Benzinga Newsdesk

July 20, 7:39 AM

Citigroup analyst Ashwin Shirvaikar maintains Genpact (NYSE:G) with a Buy and lowers the price target from $55 to $52.

Barclays Under UK Probe Over Anti-Money Laundering Systems

By Vandana Singh

February 10, 9:48 AM

The U.K.'s Financial Conduct Authority (FCA) is reportedly investigating Barclays PLC (NYSE: BCS) for suspected failings in its compliance and anti-money laundering systems.

BCS

Ford, Qualcomm And 3 Stocks To Watch Heading Into Wednesday

By Lisa Levin

May 3, 4:29 AM

With US stock futures trading mixed this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

AMD

Alliance Global Partners Downgrades T2 Biosystems to Neutral

Related Posts

Baird Downgrades Boot Barn Holdings to Neutral, Announces $86 Price Target

Citigroup Maintains Buy on Genpact, Lowers Price Target to $52

Barclays Under UK Probe Over Anti-Money Laundering Systems

Ford, Qualcomm And 3 Stocks To Watch Heading Into Wednesday